BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30352365)

  • 21. LPS-induced NFκB enhanceosome requires TonEBP/NFAT5 without DNA binding.
    Lee HH; Sanada S; An SM; Ye BJ; Lee JH; Seo YK; Lee C; Lee-Kwon W; Küper C; Neuhofer W; Choi SY; Kwon HM
    Sci Rep; 2016 Apr; 6():24921. PubMed ID: 27118681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of ADAMDEC1 correlates with tumor progression and predicts poor prognosis in non-small cell lung cancer (NSCLC) via the PI3K/AKT pathway.
    Zhu W; Shi L; Gong Y; Zhuo L; Wang S; Chen S; Zhang B; Ke B
    Thorac Cancer; 2022 Apr; 13(7):1027-1039. PubMed ID: 35178875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and inhibition of ADAMDEC1 in craniopharyngioma cells.
    Xu J; Liu L; Zheng X; You C; Li Q
    Neurol Res; 2012 Sep; 34(7):701-6. PubMed ID: 22776555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The soluble protease ADAMDEC1 released from activated platelets hydrolyzes platelet membrane pro-epidermal growth factor (EGF) to active high-molecular-weight EGF.
    Chen R; Jin G; McIntyre TM
    J Biol Chem; 2017 Jun; 292(24):10112-10122. PubMed ID: 28455445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibodies targeting the disintegrin-like domain of ADAMDEC1 modulates the proteolytic activity and enables quantification of ADAMDEC1 protein in human plasma.
    Lund J; Elimar Bitsch AM; Grønbech Rasch M; Enoksson M; Troeberg L; Nagase H; Loftager M; Overgaard MT; Petersen HH
    MAbs; 2018 Jan; 10(1):118-128. PubMed ID: 29185848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A UTX-MLL4-p300 Transcriptional Regulatory Network Coordinately Shapes Active Enhancer Landscapes for Eliciting Transcription.
    Wang SP; Tang Z; Chen CW; Shimada M; Koche RP; Wang LH; Nakadai T; Chramiec A; Krivtsov AV; Armstrong SA; Roeder RG
    Mol Cell; 2017 Jul; 67(2):308-321.e6. PubMed ID: 28732206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR‑101‑3p negatively regulates inflammation in systemic lupus erythematosus via MAPK1 targeting and inhibition of the NF‑κB pathway.
    Zhao X; Li S; Wang Z; Bai N; Feng Y
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NFκB- and AP-1-mediated DNA looping regulates matrix metalloproteinase-9 transcription in TNF-α-treated human leukemia U937 cells.
    Chen YJ; Chang LS
    Biochim Biophys Acta; 2015 Oct; 1849(10):1248-59. PubMed ID: 26260845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An enhancer element harboring variants associated with systemic lupus erythematosus engages the TNFAIP3 promoter to influence A20 expression.
    Wang S; Wen F; Wiley GB; Kinter MT; Gaffney PM
    PLoS Genet; 2013; 9(9):e1003750. PubMed ID: 24039598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates beta-catenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells.
    Bourguignon LYW; Xia W; Wong G
    J Biol Chem; 2009 Jan; 284(5):2657-2671. PubMed ID: 19047049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circular RNA expression profile and potential function of hsa_circ_0045272 in systemic lupus erythematosus.
    Li LJ; Zhu ZW; Zhao W; Tao SS; Li BZ; Xu SZ; Wang JB; Zhang MY; Wu J; Leng RX; Fan YG; Pan HF; Ye DQ
    Immunology; 2018 Sep; 155(1):137-149. PubMed ID: 29700819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The co-activator p300 associates physically with and can mediate the action of the distal enhancer of the FGF-4 gene.
    Nowling T; Bernadt C; Johnson L; Desler M; Rizzino A
    J Biol Chem; 2003 Apr; 278(16):13696-705. PubMed ID: 12488456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ADAMDEC1 accelerates GBM progression
    Qi H; Wang P; Sun H; Li X; Hao X; Tian W; Yu L; Tang J; Dong J; Wang H
    Front Oncol; 2022; 12():945025. PubMed ID: 36172139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of new Rel/NFkappaB regulatory networks by focused genome location analysis.
    De Siervi A; De Luca P; Moiola C; Gueron G; Tongbai R; Chandramouli GV; Haggerty C; Dzekunova I; Petersen D; Kawasaki E; Kil WJ; Camphausen K; Longo D; Gardner K
    Cell Cycle; 2009 Jul; 8(13):2093-100. PubMed ID: 19502793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic assembly and activation of estrogen receptor α enhancers through coregulator switching.
    Murakami S; Nagari A; Kraus WL
    Genes Dev; 2017 Aug; 31(15):1535-1548. PubMed ID: 28887413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knockdown of ADAMDEC1 inhibits the progression of glioma in vitro.
    Liu X; Huang H; Li X; Zheng X; Zhou C; Xue B; He J; Zhang Y; Liu L
    Histol Histopathol; 2020 Sep; 35(9):997-1005. PubMed ID: 32378728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Krüppel-associated box-associated protein 1 negatively regulates TNF-α-induced NF-κB transcriptional activity by influencing the interactions among STAT3, p300, and NF-κB/p65.
    Kamitani S; Togi S; Ikeda O; Nakasuji M; Sakauchi A; Sekine Y; Muromoto R; Oritani K; Matsuda T
    J Immunol; 2011 Sep; 187(5):2476-83. PubMed ID: 21810609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular RNA liberates tumor necrosis factor-α to promote tumor cell trafficking and progression.
    Fischer S; Gesierich S; Griemert B; Schänzer A; Acker T; Augustin HG; Olsson AK; Preissner KT
    Cancer Res; 2013 Aug; 73(16):5080-9. PubMed ID: 23774209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of p300 alleviates LPS-induced inflammatory injuries through regulation of RhoA/ROCK/NF-κB pathways in A549 cells.
    Liu Q; Yang H; Xu S; Sun X
    Biomed Pharmacother; 2018 Jan; 97():369-374. PubMed ID: 29091886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional Landscape of Enhancer RNAs in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus.
    Guo G; Wang H; Tong X; Ye L; Shi X; Fang S; Hu Y; Han F; Chen C; Ding N; Su B; Xue X; Zhang H
    J Inflamm Res; 2022; 15():775-791. PubMed ID: 35153501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.